Kerri Kaplan

Kerri Kaplan is an accomplished regulatory affairs professional with extensive experience in the pharmaceutical industry. Currently serving as the Executive Director and Global Regulatory Therapeutic Area Lead at Biogen since September 2021, Kerri specializes in Specialized Immunology, Neuropsychiatry, Alzheimer’s Disease, and Parkinson’s Disease. Prior to Biogen, Kerri held positions as Executive Director of Global Regulatory Affairs at AbbVie and Allergan, and progressed through various regulatory affairs roles at Dompé, Forest Laboratories, and Atlanta Center for Medical Research. Kerri holds a PharmD from Long Island University, a post-doctoral fellowship in Clinical Development and Regulatory Affairs from St. John's University, and a B.A. in Psychology from Auburn University.